Showing results (131-140 of 291) with videos related to

Sort By:
Pageof 30
Acta Cytologica|August 20, 2020
Characteristic Cytological Findings of Lobular Endocervical Glandular Hyperplasia Associated with Adenocarcinoma of the Uterine CervixShuhei Ishii, Takahiko Ito, Marisa Yamada, et al.
Pathology, Research and Practice|December 1, 2019
Giant cell tumor of soft tissue of the breast: Case report with H3F3A mutation analysis and review of the literatureThitsamay Luangxay, Tomo Osako, Rika Yonekura, et al.
International Journal of Hematology|January 16, 2020
Insignificance of surveillance imaging in patients with diffuse large B-cell lymphoma who achieved first complete remission: a retrospective cohort studyTakanori Fukuta, Noriko Nishimura, Yuko Shirouchi, et al.
Cancer Science|April 13, 2022
The ELEANOR noncoding RNA expression contributes to cancer dormancy and predicts late recurrence of estrogen receptor-positive breast cancerMegumi Fukuoka, Yuichi Ichikawa, Tomo Osako, et al.
Annals of Hematology|November 16, 2017
Delayed recovery of serum immunoglobulin G is a poor prognostic marker in patients with follicular lymphoma treated with rituximab maintenanceYoshiharu Kusano, Masahiro Yokoyama, Norihito Inoue, et al.
Cancer Letters|June 20, 2022
Acquired resistance to BRAF inhibitors is mediated by BRAF splicing variants in BRAF V600E mutation-positive colorectal neuroendocrine carcinomaYuki Shimizu, Kohei Maruyama, Mai Suzuki, et al.
Haematologica|September 28, 2014
Absolute peripheral monocyte count at diagnosis predicts central nervous system relapse in diffuse large B-cell lymphomaHideaki Nitta, Yasuhito Terui, Masahiro Yokoyama, et al.
The Journal of Medical Investigation : JMI|September 29, 2017
The case of double primary lung adenocarcinomas with an EGFR mutation and ALK translocation successfully treated with alectinib at the post-surgical recurrenceYoshio Tsunezuka, Nobuyoshi Tanaka, Hideki Fujimori, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 7, 2009
An imaging-based rapid evaluation method for complement-dependent cytotoxicity discriminated clinical response to rituximab-containing chemotherapyYuji Mishima, Natsuhiko Sugimura, Yuko Matsumoto-Mishima, et al.
The American Journal of Surgical Pathology|September 5, 2021
Distinct Clinicopathologic Features and Possible Pathogenesis of Localized ALK-positive Histiocytosis of the BreastTomo Osako, Aiko Kurisaki-Arakawa, Akito Dobashi, et al.
Pageof 30